INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.

Abstract

PURPOSE To evaluate the safety and efficacy of intravitreal dexamethasone implant (Ozurdex) for treating refractory macular edema in retinal vascular diseases. METHODS This is a retrospective consecutive series of 53 eyes with refractory macular edema secondary to central retinal vein occlusion (13 eyes), branch retinal vein occlusion (14 eyes), and… (More)
DOI: 10.1097/IAE.0000000000000616

Topics

Cite this paper

@article{Alshahrani2016INTRAVITREALDI, title={INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.}, author={Saeed T Alshahrani and Rosa Dolz-Marco and Roberto Gallego-Pinazo and Manuel J D{\'i}az-Llopis and J Fernando Arevalo}, journal={Retina}, year={2016}, volume={36 1}, pages={131-6} }